Lv1
40 积分 2022-09-16 加入
ENTERPRET: a randomized controlled trial of vedolizumab dose optimization in patients with ulcerative colitis who have early nonresponse
10个月前
已完结
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
10个月前
已完结
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
10个月前
已完结
The incidence and management of infusion reactions to infliximab: a large center experience
10个月前
已完结
Breaking Through the Therapeutic Ceiling: What Will It Take?
10个月前
已完结
皖公网安备34019202002308
